Piotr Barus
Overview
Explore the profile of Piotr Barus including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
33
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bednarek A, Gumiezna K, Barus P, Kochman J, Tomaniak M
J Clin Med
. 2025 Jan;
14(2).
PMID: 39860467
The precision of imaging and the number of other risk-assessing and diagnostic methods are constantly growing, allowing for the uptake of additional strategies for individualized therapies. Personalized medicine has the...
2.
Milewski K, Pawlowski T, Kidon-Szoltysek J, Tomaniak M, Gora B, Barus P, et al.
Kardiol Pol
. 2025 Jan;
82(12):1307-1322.
PMID: 39775563
No abstract available.
3.
Barus P, Hunia J, Kaczorowski R, Bednarek A, Ochijewicz D, Gumiezna K, et al.
Med Sci Monit
. 2024 May;
30:e943956.
PMID: 38720443
BACKGROUND Progression of chronic coronary syndrome (CCS) is influenced by chronic kidney disease (CKD). This 5-year follow-up study aimed to assess 100 patients with 118 intermediate coronary artery lesions evaluated...
4.
Gumiezna K, Bednarek A, Sygitowicz G, Maciejak-Jastrzebska A, Barus P, Hunia J, et al.
J Clin Med
. 2024 Jan;
13(1).
PMID: 38202070
Introduction: Patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI) require dual antiplatelet therapy (DAPT). However, the response to treatment can vary considerably. Certain platelet microRNAs (miRs) are...
5.
Gumiezna K, Barus P, Sygitowicz G, Wisniewska A, Bednarek A, Zablocki J, et al.
J Cardiovasc Pharmacol Ther
. 2024 Jan;
29:10742484231202864.
PMID: 38196286
Platelets are strongly associated with cardiovascular events due to their role in thrombotic processes. Reticulated platelets have higher prothrombotic potential. The aim of the study was to evaluate the effectiveness...
6.
Gumiezna K, Bednarek A, Sygitowicz G, Barus P, Wisniewska A, Klimczak-Tomaniak D, et al.
Adv Clin Exp Med
. 2023 Dec;
32(12):1465-1470.
PMID: 38126718
Background: Antiplatelet therapy is the cornerstone of treatment for patients presenting with acute coronary syndrome (ACS) treated with percutaneous coronary intervention (PCI). Some patients may not respond to such therapy...
7.
Barus P, Piasecki A, Gumiezna K, Bednarek A, Dunaj P, Glod M, et al.
Front Cardiovasc Med
. 2023 Jul;
10:1021023.
PMID: 37424919
Background: The pathophysiology of atherosclerotic plaque formation and its vulnerability seem to differ between genders due to contrasting risk profiles and sex hormones, however this process is still insufficiently understood....
8.
Skladanek J, Leskiewicz M, Gumiezna K, Barus P, Piasecki A, Klimczak-Tomaniak D, et al.
Adv Clin Exp Med
. 2023 Jun;
33(3):299-308.
PMID: 37386857
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has caused high morbidity and mortality and has been a source of substantial challenges for healthcare systems globally. Despite a full...
9.
Starczynski M, Dudek S, Barus P, Niedzieska E, Wawrzenczyk M, Ochijewicz D, et al.
Diagnostics (Basel)
. 2023 Jun;
13(12).
PMID: 37371012
Today, coronary artery disease (CAD) continues to be a prominent cause of death worldwide. A reliable assessment of coronary stenosis represents a prerequisite for the appropriate management of CAD. Nevertheless,...
10.
Gumiezna K, Barus P, Sygitowicz G, Wisniewska A, Ochijewicz D, Pasierb K, et al.
Cardiol J
. 2023 Mar;
30(5):817-824.
PMID: 36908161
Immature platelet fraction (IPF), circulating platelets still containing RNA, can be easily calculated by automated flow cytometry, this makes them an accessible biomarker. Higher IPF concentrations were reported in patients...